I dont think any company that is undervalued is immune to take over. But between tribe Hopkins x2 David and Barton there is plenty of blocking capability. If their dmd drug works well and it is only one of potentially many drugs they wont let this go for under 1-2 billion. They might not let it go even then. Sarepta is worth 10billion on the back of one drug.
I feel we have several rebates coming this year, hoping the first starts pretty soon as sp is tedious at this level and i keep buying more.
PYC Price at posting:
3.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)